Mobile, Ala. (WKRG) – Lung cancer remains the leading cause of cancer-related deaths in the United States, but new advances in early detection are giving physicians more opportunities to diagnose the ...

A new international expert consensus statement published in The Lancet Respiratory Medicine provides guidance for doctors on how to identify, monitor and treat a serious lung complication that affects ...

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely ...

IRVING, Texas, July 1, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the ...

A Nature Medicine paper landed on Feb. 2 like a stone in a pond, sending out ripples that quickly turned into tidal waves across biomedical circles. By midday, renowned physician-scientist Eric Topol, ...

A new program aims to improve early detection of lung cancer in Illinois, according to a community announcement. The Amy Keil Schmidt Early Lung Cancer Detection Program will expand access to ...

Would you plant a chip in your brain if it promised to detect or even prevent cancer? Three people agreed to do just that. San Francisco-based longevity company Coherence Neuro briefly placed an ...

SPRINGFIELD — Prior to her death from lung cancer in 2025, Springfield attorney Amy Keil Schmidt emphasized the importance of early detection of the disease in a social media post: If caught at Stage ...

The startup Coherence Neuro is now testing a brain-computer interface that could one day use electrical stimulation to prevent tumors from growing. Coherence Neuro says it temporarily placed its ...

Continuing with ongoing trial that combines drug with Keytruda Plans to explore using the drug with other experimental treatments Shares fall 1% June 22 (Reuters) - Pfizer (PFE.N), opens new tab said ...

Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri ...